Physician profile
Tierney Shea
NPI 1952829582
$2,079.65
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,703 · 2022: $376.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $272.93 | 2021-2022 | |
| Novo Nordisk INC | $261.91 | 2021-2022 | |
| Astellas Pharma US INC | $234.26 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $134.61 | 2021 | |
| Abbvie INC. | $125.39 | 2021-2022 | |
| Pfizer INC. | $98.49 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.38 | 2021-2022 | |
| Lilly USA, LLC | $96.87 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $78.69 | 2021 | |
| Amarin Pharma, INC. | $77.75 | 2021 | |
| Abbott Laboratories | $74.19 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $65.00 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.36 | 2021-2022 | |
| Glaxosmithkline, LLC. | $48.10 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.87 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $46.78 | 2021 | |
| Corcept Therapeutics | $38.38 | 2021 | |
| Medicure Pharma INC. | $35.55 | 2021 | |
| Eisai INC. | $24.61 | 2021 | |
| Merck Sharp & Dohme LLC | $24.61 | 2021 | |
| Boston Scientific Corporation | $22.38 | 2021 | |
| Janssen Pharmaceuticals, INC | $19.70 | 2021 | |
| Insulet Corporation | $18.85 | 2021 | |
| Xeris Pharmaceuticals, INC. | $18.26 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.28 | 2022 | |
| Nevro Corp. | $14.13 | 2021 | |
| Collegium Pharmaceutical, INC. | $13.79 | 2021 | |
| Currax Pharmaceuticals LLC | $13.13 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.40 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tierney Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.